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Abstract 
 
The pre- and postsynaptic actions of exogenously applied ATP were investigated in intact 
and dissociated parasympathetic neurones of rat submandibular ganglia. Nerve-evoked 
excitatory postsynaptic potentials (EPSPs) were not inhibited by the purinergic receptor 
antagonists, suramin and pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), 
or the desensitising agonist, α,β-methylene ATP. In contrast, EPSPs were abolished by the 
nicotinic acetylcholine receptor antagonists, hexamethonium and mecamylamine. Focal 
application of ATP (100 μM) had no effect on membrane potential of the postsynaptic 
neurone or on the amplitude of spontaneous EPSPs. Taken together, these results suggest the 
absence of functional purinergic (P2) receptors on the postganglionic neurone in situ. In 
contrast, focally applied ATP (100 μM) reversibly inhibited nerve-evoked EPSPs. Similarly, 
bath application of the non-hydrolysable analogue of ATP, ATPγS, reversibly depressed 
EPSPs amplitude. The inhibitory effects of ATP and ATPγS on nerve-evoked transmitter 
release were antagonised by bath application of either PPADS or suramin, suggesting ATP 
activates a presynaptic P2 purinoceptor to inhibit acetylcholine release from preganglionic 
nerves in the submandibular ganglia. In acutely dissociated postganglionic neurones from rat 
submandibular ganglia, focal application of ATP (100 μM) evoked an inward current and 
subsequent excitatory response and action potential firing, which was reversibly inhibited by 
PPADS (10 μM). 
The expression of P2X purinoceptors in wholemount and dissociated submandibular 
ganglion neurones was examined using polyclonal antibodies raised against the extracellular 
domain of six P2X purinoceptor subtypes (P2X1–6). In intact wholemount preparations, only 
the P2X5 purinoceptor subtype was found to be expressed in the submandibular ganglion 
neurones and no P2X immunoreactivity was detected in the nerve fibres innervating the 
ganglion. Surprisingly, in dissociated submandibular ganglion neurones, high levels of P2X2 
and P2X4 purinoceptors immunoreactivity were found on the cell surface. This increase in 
expression of P2X2 and P2X4 purinoceptors in dissociated submandibular neurones could 
explain the increased responsiveness of the neurones to exogenous ATP. 
We conclude that disruption of ganglionic transmission in vivo by either nerve 
damage or synaptic blockade may up-regulate P2X expression or availability and alter 
neuronal excitability.  
 
Author Keywords: acetylcholine; P2X receptors; synaptic transmission; electrophysiology; 
immunohistochemistry  
 
 
 
There is increasing evidence that ATP plays a role in neurotransmission in mammalian autonomic ganglia (for 
review see Ralevic and Burnstock, 1998). Extracellular ATP can activate a number of different receptors, 
termed P2 purinoceptors, which can be classified into two groups, P2X and P2Y purinoceptors. P2X 
purinoceptors are ligand-gated cation channels and P2Y purinoceptors are G protein-coupled receptors 
associated with intracellular second messengers. P2X receptors are widely distributed throughout the tissues of 
 
Neuroscience (2001) 107 (2), 283-291.  doi: 10.1016/S0306-4522(01)00347-5 
 
the body, including some synapses where ATP can function as a neurotransmitter ( Edwards; Silinsky and 
Galligan). Molecular cloning has confirmed the existence of at least seven distinct P2X subunits (P2X1–7) 
(Hansen and Ralevic), although the putative P2X8 has recently been demonstrated in avian skeletal muscle (Bo 
et al., 2000). Individual P2X purinoceptor subunits, however, are not expressed uniformly in all cell types ( 
Dutton et al., 1999). 
Purinergic P2 receptors have been shown to be located pre- and postysynaptically on neurones in the 
central and peripheral nervous systems (Sperlagh; Evans; Galligan; von and Le). Studies carried out on cultured 
mammalian autonomic neurones have shown that focal application of ATP evokes a rapid inward current ( 
Fieber; Evans and Galligan). These observations have been extended in cultured guinea-pig submucosal and 
myenteric neurones to demonstrate that ATP mediates fast excitatory postsynaptic currents and acts as a 
neurotransmitter ( Zhou and Galligan, 1996). Furthermore, P2X and nicotinic acetylcholine receptors (nAChRs) 
have been linked in a mutually inhibitory fashion in guinea-pig myenteric neurones ( Zhou and Galligan, 1998). 
P2X purinoceptors and nAChRs have been localised on the same preganglionic nerve in chick ciliary ganglia ( 
Sun and Stanley, 1996) and dissociated vagal preganglionic neurones in the rat ( Nabekura et al., 1995). 
The aim of the present study was to investigate ATP modulation of acetylcholine (ACh) release from 
the intact preganglionic nerve terminals of the rat submandibular ganglia, and to determine which, if any, P2X 
purinoceptors are located in the intact and dissociated parasympathetic ganglion neurones. A preliminary 
account of these results has been published in abstract form (Smith and Adams, 1998). 
 
Experimental Procedures 
 
Preparation – submandibular ganglia 
 
Two–four week old rats (Central Animal Breeding House, University of Queensland, Qld., Australia) were 
anaesthetised with sodium pentobarbitone and killed by cervical fracture prior to removal of the submandibular 
ganglia. Experimental procedures were in accordance with the guidelines of the University of Queensland 
Animal Experimentation Committee and all efforts were made to minimise animal suffering and the number of 
animals used. The submandibular ganglia were exposed and removed as previously described (Kawa and Roper, 
1984). Individual preparations were pinned to the Sylgard (Dow-Corning)-covered base of a 2-ml Perspex organ 
bath. Preparations were perfused with a Krebs solution of the following composition (mM): NaCl 118.4, 
NaHCO3 25.0, NaH2PO4 1.13, CaCl2 1.8, KCl 4.7, MgCl2 1.3 and glucose 11.1, gassed with a mixture of 95% 
O2 and 5% CO2 to pH 7.4, and maintained at 36–37°C. 
 
Intracellular recording and analysis 
 
The lingual nerve was field-stimulated by rectangular voltage pulses via bare platinum wires delivered from a 
digital stimulator (Pulsar 7+; Frederick Haer and Company, Brunswick, ME, USA) coupled to an optically 
isolated stimulation unit (Model DS2; Digitimer Ltd., Welwyn Garden City, UK). Intracellular recordings were 
made from individual ganglion cells using glass microelectrodes filled with 5 M potassium acetate (resistances 
70–120 MΩ). Conventional intracellular recording techniques were used as described previously (Seabrook and 
Smith). Membrane potentials were recorded through a headstage connected to an Axoclamp-2A amplifier (Axon 
Instruments, Foster City, CA, USA) in bridge mode and stored on a digital tape recorder (DTR-1204; BioLogic 
Science Instruments, Claix, France). Evoked events were digitised at 5–10 kHz and transferred to a Pentium 
computer using an analogue-to-digital converter (TL-1 DMA interface) and Axotape software (Axon 
Instruments). The amplitude, frequency, rise time and latency of evoked and spontaneous events were analysed 
using the program, Axograph 2 (Axon Instruments). The mean resting membrane potential of the submandibular 
ganglion neurones was −66.3±0.6 mV (n=70). The mean baseline was determined by averaging the initial part 
of the digitised signal between the stimulus artifact and the onset of the response. Data are expressed as the 
mean±S.E.M. and n values refer to the number of preparations. Data were analysed statistically using Student’s 
paired t-test with the level of significance being taken as P<0.05. 
 
Whole-cell patch clamp recording of acutely dissociated neurones 
 
Current and voltage recordings were made from isolated neurones 3–4 h after dissociation from submandibular 
ganglia from 2–4 week old rats. The procedure for isolation of the neurones from rat submandibular ganglia 
have been described in detail previously (Liu and Adams, 2001). Electrical access to the cell interior was 
obtained using the whole-cell recording configuration of the patch clamp technique ( Hamill et al., 1981). 
Pipettes were pulled from thin wall borosilicate glass (Harvard Apparatus Ltd., Edenbridge, Kent, UK) using a 
Sutter Instruments P-87 pipette puller and following fire polishing had resistances of 1 MΩ. The intracellular 
pipette solution contained (in mM): 140 CsCl, 2 MgATP, 2 Cs4-1,2-bis-(2-aminophenoxy)ethane-N,N,N′,N′-
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tetraacetic acid (BAPTA) and 10 HEPES–CsOH, pH 7.2. Access resistances using the dialysed whole-cell 
recording configuration were ≤2 MΩ following series resistance compensation. 
Membrane currents and voltages were recorded using an Axopatch 200B patch clamp amplifier (Axon 
Instruments). Voltage and current protocols were applied using pClamp software (Version 6.1.2, Axon 
Instruments). Purinoceptor-mediated responses were evoked by focal application of a maximally effective 
concentration of ATP (100 μM) via pressure ejection (10 psi; Picospritzer II, General Valve, Fairfield, NJ USA) 
from an extracellular pipette positioned 50 μm from the soma membrane. Signals were filtered at 1 kHz then 
digitised at 5 kHz (Digidata 1200 interface, Axon Instruments) and stored on the hard disc of a PC (Pentium II) 
for viewing and analysis. 
 
Immunohistochemistry 
 
The immunohistochemical protocol was based on previous specific P2X purinoceptor immunostaining 
procedures (Hansen and Hansen). Submandibular ganglia preparations, either wholemount or cell cultures, were 
fixed in 4% paraformaldehyde in borate–acetate buffer (pH 9.5) for 1 h. Preparations were placed in 0.1% 
dimethyl sulphoxide (DMSO) in phosphate-buffered foetal bovine serum (FBS) (100 ml phosphate-buffered 
saline (PBS), 2 ml FBS, 0.1 ml Triton X-100, 1 g bovine serum albumin) for 30 min. The preparation was then 
washed three times in PBS (10 min each) and immersed in 20% FBS in PBS for 1 h to block non-specific 
binding sites in the tissue. This was followed by incubation with 1:100 anti-synaptophysin antibody together 
with the relevant 1:100 anti-P2X antibody for 24 h at 25°C. Slides were rinsed in PBS followed by the addition 
of the relevant secondary fluorescent antibodies for 90 min at 25°C. The slides were washed three times in PBS 
(each for 10 min), coverslipped and sealed. Sections were viewed on a Bio-Rad M600 UV laser confocal 
microscope system, with standard settings. 
 
Drugs 
 
Drugs were dissolved in the Krebs solution perfusing the preparation. The following drugs were used: ATP, 
adenosine 5′-O-(3-thiotriphosphate) (ATPγS), α-bungarotoxin, κ-bungarotoxin (Calbiochem-Novabiochem, 
Croyden, Vic., Australia), hexamethonium chloride, mecamylamine and α,β-methylene adenosine 5′-
triphosphate (α,β-MeATP Sigma-Aldrich Pty Ltd, Castlehill, NSW, Australia), 2-methylthioadenosine 
triphosphate tetrasodium salt (2-methylthio-ATP), suramin, pyridoxal-phosphate-6-azophenyl-2′, 4′-disulphonic 
acid (Research Biochemicals, Natick, MA, USA); and pentobarbitone sodium (Boehringer Ingelheim Pty., 
Artarmon, NSW, Australia). The P2X antibodies used were a gift from Dr. Julian Barden (University of 
Sydney) and have been characterised previously (Hansen and Hansen). Anti-mouse synaptophysin antibody 
specific for neuronal synaptic vesicle membranes was purchased from the DAKO Corporation (Carpinteria, CA, 
USA). All other immunohistochemical reagents were purchased from Sigma. 
 
Results 
 
Effects of purinoceptor antagonists on excitatory postsynaptic potential (EPSP) 
 
Stimulation of the lingual nerve with trains of stimuli (0.1–50 Hz, 4–50 V, pulse width 0.05–0.25 ms) evoked 
EPSPs which could initiate action potentials in the cell bodies of the postsynaptic neurones of the rat 
submandibular ganglion (Seabrook and Adams, 1989). The postganglionic neurones studied (n>150) can be 
classified into three types by their responses to these trains of stimuli: (i) neurones in which supramaximal 
stimulation of the preganglionic nerve fibres at 0.1 Hz evokes a suprathreshold EPSP and action potential in 
response to every stimulus (strong input synapse, approximately 50% of total number of cells studied), (ii) 
neurones where the EPSP evoked by supramaximal stimulation does not usually reach threshold for the 
initiation of an action potential (weak input synapse, approximately 25% of total number of cells studied), and 
(iii) neurones that receive multiple synaptic inputs (approximately 25% of total number of cells studied), cell 
bodies being innervated by two or more preganglionic axons (Kawa and Smith). 
To examine whether ATP was co-released with ACh, the effects of the following purinoceptor 
antagonists on the nerve-evoked postsynaptic response were investigated. The P2 receptor antagonists, suramin 
(10–300 μM) and pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS, 100 μM) and the 
desensitising agonist, α,β-methylene ATP (10 μM) had no detectable effects on neurotransmitter release (Fig. 1) 
in any of the ganglion cell types studied or on the resting membrane potential of the postsynaptic neurone. 
EPSPs recorded from cells receiving strong or weak inputs were abolished by either hexamethonium (30–100 
μM) or mecamylamine (10 μM; Fig. 2A) indicating that EPSPs were mediated by ACh acting at postsynaptic 
nAChRs. κ-bungarotoxin (100 nM) inhibited the nerve-evoked EPSP by ≥60% indicating that the nAChRs 
contain the α3β2 subunits (Luetje et al., 1990). In contrast, α-bungarotoxin (1 μM) produced no detectable 
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effects on EPSPs ( Fig. 2B) suggesting that the nAChRs mediating neurotransmission at this synapse do not 
contain the α7 subunit.  
 
 
 
 
 
 
 
In cultured intracardiac ganglion neurones, focal application of ATP evokes a rapid depolarisation and 
action potentials (Fieber and Adams, 1991). In the intact submandibular ganglion preparation, focal application 
of ATP (100 μM) had no effect on the resting membrane potential of the postsynaptic neurone or on the 
amplitude or frequency of spontaneous EPSPs (n=11). However, ATP focally applied during a train of nerve 
stimulation caused potent inhibitory effects on neurotransmitter release in all neurones studied (strong, weak and 
multiple input neurones). Fig. 3 shows the effect of ATP (100 μM) on 12 consecutive responses to nerve 
stimulation at 0.4 Hz. During the focal application of ATP, the EPSP greatly decreased in amplitude, an effect 
that was rapidly reversible as the ATP is broken down and washed away. EPSPs returned to control amplitude 
approximately 10 s after the termination of ATP application. Measurements of EPSP amplitude were made at 
synapses where the nerve-evoked EPSP did not reach threshold for action potential firing. Control EPSPs had a 
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mean amplitude of 38.6±3.6 mV and after a 10 s focal application of ATP (100 μM), EPSPs had a mean 
amplitude of 15.7±3.3 mV (n=11), a 59% inhibition. 
 
 
 
 
 
Similar experiments were carried out using the non-hydrolysable analogue of ATP, adenosine 5′-O-(3-
thiophosphate) (ATPγS). ATPγS had no detectable effect on the resting membrane potential of the cell or on the 
frequency or amplitude of spontaneous EPSPs (n=9; data not shown). Fig. 4A shows the effect of ATPγS (100 
μM) on 12 consecutive responses to nerve stimulation at 0.4 Hz. During the focal application of ATPγS, the 
EPSPs dramatically decreased in size, an effect that was more slowly reversible than ATP since ATPγS is not 
broken down. EPSP amplitude returned to control approximately 2 min after the termination of the application. 
Control EPSPs had a mean amplitude of 21.8±2.8 mV which decreased to 5.4±1.2 mV (n=9) after a 10 s focal 
application of ATPγS (100 μM), a 75% inhibition. 
Bath application of ATPγS (10–100 μM) also caused an inhibition of neurally evoked transmitter 
release (Fig. 4B). Control EPSPs had a mean amplitude of 30.4±2.4 mV and 10 min after the bath application of 
ATPγS (10 μM) EPSPs had a mean amplitude of 18.0±2.9 mV (n=7), a 40% inhibition. 2-Methylthio-ATP (100 
μM) caused a slight inhibition ( 20%) of evoked transmitter release (not shown). Control EPSPs had a mean 
amplitude of 30.4±2.5 mV and 20 min after bath application of 2-methylthio-ATP (100 μM) EPSPs had a mean 
amplitude of 24.0±2.8 mV (n=5). UTP (100 μM) had no detectable effects on the amplitude of EPSPs or the 
membrane potential of the postsynaptic neurone (n=3, not shown). 
The inhibitory effects of ATP and ATPγS on neurally evoked transmitter release could be reversibly 
antagonised by the bath application of either suramin (10 μM) or PPADS (10 μM; Fig. 5). These results suggest 
that ATP acts presynaptically through a P2 purinoceptor to inhibit ACh release from preganglionic nerves in rat 
parasympathetic ganglia.  
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ATP-evoked responses in acutely dissociated postganglionic neurones 
 
Given that focal application of exogenous ATP to the postganglionic neurones of rat submandibular ganglia did 
not evoke a membrane response, a series of experiments were carried out on acutely dissociated submandibular 
ganglion neurones. Focal application of 100 μM ATP to isolated neurones within 3–4 h of dissociation from rat 
submandibular ganglia evoked an excitatory, depolarising response and action potential firing (control, Fig. 6A). 
In all acutely dissociated neurones studied, ATP (100 μM) evoked a membrane depolarisation >20 mV 
sufficient to reach threshold for action potential firing from a resting membrane potential of −52.1±2.4 mV 
(n=9). Bath application of PPADS (10 μM) reversibly inhibited the ATP-induced depolarisation and action 
potential firing (+PPADS, Fig. 6A) indicating that the excitatory response was mediated by the activation of P2 
purinoceptors. Under voltage clamp conditions, brief application (10-ms pulse) of 100 μM ATP applied to soma 
membrane held at −60 mV evoked a rapid, transient inward current in >90% of the neurones studied (control, 
Fig. 6B). The peak current density of the ATP-evoked inward current at −60 mV was 9.6±0.9 pA/pF (n=6). The 
ATP-evoked inward current was also reversibly inhibited by bath application of 10 μM PPADS (+PPADS, Fig. 
6B). The ATP-evoked inward current is consistent with activation of non-selective cation P2X receptor-
channels described in detail previously in dissociated neurones of rat parasympathetic ganglia (Fieber and Liu).  
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Expression of P2X receptors in wholemount and cultured preparations 
 
A monoclonal antibody against synaptophysin was used to identify nerves and ganglia in the tissue. 
Synaptophysin is a protein component of synaptic vesicles that are found in almost all neurones (Navone et al., 
1986). Double labelling experiments conducted with anti-synaptophysin and anti-P2X antibodies allowed P2X 
immunoreactivity to be described in relation to the ganglia and surrounding nerves. 
Antibodies raised against individual P2X receptor subtypes (P2X1–6) were used to determine if any P2X 
receptor subtypes were expressed in the submandibular ganglia. These P2X receptor antibodies have been 
shown previously to be specific for each P2X receptor subtype (Dutton and Worthington). Control antibody 
protocols were undertaken to check for any non-specific immunoreactivity within the tissue. No 
immunoreactivity was seen in any structures examined when normal serum was incubated in place of the 
primary antibody. Therefore any immunoreactivity observed would indicate the expression of a specific ligand-
gated P2X purinoceptors in postganglionic neurones. Only one P2X subtype, P2X5, was found expressed within 
the submandibular ganglion intact wholemount preparation (n=41, Fig. 7C,D). The P2X5 immunoreactivity 
demonstrated was predominantly of the small punctate variety that has been previously found in other tissues 
such as the bladder (Dutton et al., 1999) and heart ( Hansen et al., 1999b). It is expected that labelling would be 
localised to the submandibular ganglion cells only, as the P2X5 antibody is raised to the extracellular domain of 
the P2X receptor. Furthermore, little cellular permeabilisation was carried out and no P2X immunoreactivity 
was detected in associated synaptophysin-labelled nerve fibres to the individual ganglia (Fig. 7A,B). 
 
 
 
In cultured submandibular ganglion neurones, immunoreactivity could still be discerned for P2X5, at a 
level similar to that in the intact preparation (Fig. 8E), however, immunoreactivity for the other P2X receptor 
subtypes examined (i.e. P2X1–4 and P2X6) could also be detected. High levels of P2X2 and P2X4 
immunoreactivity were found in the cultured preparations. The P2X2 immunoreactivity was localised at the cell 
membranes (Fig. 8B), whereas the P2X4 immunoreactivity was seen diffusely throughout the cells (Fig. 8D). 
Very low levels of P2X1, P2X3 and P2X6 were detected in some cultured preparations, with the 
immunoreactivity confined to the membranes of the individual cells (Fig. 8A,C,F).  
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Discussion 
 
The effects of exogenously applied ATP on intact and dissociated parasympathetic neurones were investigated. 
In the intact rat submandibular ganglia, synaptic transmission was unaffected by P2X purinoceptor antagonists 
but abolished by nAChR antagonists. These data suggest that ACh is the sole excitatory neurotransmitter at 
synapses within this ganglia which is consistent with that reported previously in intact guinea-pig sympathetic 
ganglia (Inokuchi and McLachlan, 1995). 
Focal application of ATP or the non-hydrolysable analogue ATPγS (100 μM) had no effect on the 
membrane potential of the postganglionic neurone or on the amplitude of spontaneous EPSPs. Taken together, 
these results suggest the absence of functional purinergic receptors on the postsynaptic neurone in situ. 
However, focal application of ATP and ATPγS and bath application of ATPγS potently and reversibly inhibited 
nerve-evoked transmitter release in the submandibular ganglia. The absence of any effect on either the resting 
membrane potential of the postsynaptic neurone or the amplitude and frequency of spontaneous EPSPs suggests 
that the inhibitory effect is presynaptic in nature and that there are no functional P2 purinoceptors 
postsynaptically. 
The P2 purinoceptor antagonists, suramin and PPADS blocked the presynaptic inhibition of evoked 
transmitter release by ATP and ATPγS. This result suggests that ATP acts through presynaptic P2 
purinoceptors. The P2 purinoceptor agonist, 2-methylthio-ATP, caused a slight inhibition ( 20%) of EPSP 
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amplitude but UTP had no detectable effects on evoked transmitter release. Taken together, the agonist potency 
profile for inhibition of neurotransmitter release suggests a presynaptic P2Y purinoceptor is activated by the P2 
agonists, possibly a P2Y1 or a P2Y11 receptor subtype (Ralevic and Burnstock, 1998). 
In acutely dissociated postganglionic neurones from rat submandibular ganglia, focal application of 
ATP evoked an inward current and subsequent excitatory depolarising response and action potential firing, 
which was reversibly inhibited by PPADS, consistent with activation of P2X purinoceptors (Ralevic and 
Burnstock, 1998). This result is in contrast to the results from the intact submandibular ganglia preparation but 
consistent with previous studies on cultured neurones from rat intracardiac ganglia ( Fieber and Adams, 1991). 
The question arises whether P2X purinoceptor expression is up-regulated or becomes functionally available 
when the postganglionic neurones are dissociated. 
To determine which P2X receptor subtypes are present in submandibular ganglion cells, 
immunohistochemistry, using specific polyclonal antibodies, was undertaken. P2X5 subunit immunoreactivity 
was detected in the intact preparation, however, it was only found intracellularly. In dissociated ganglion 
neurones the levels of P2X2 and P2X4 immunoreactivity are substantially increased. Up-regulation of P2X4 
expression has been demonstrated previously in parasympathetic ganglion preparations (Tenneti et al., 1998). 
P2X4 up-regulation in rat parotid cells occurs following parasympathetic denervation suggesting that there are 
presynaptic factors regulating P2X expression. Inhibition of neurotransmitter release with tetrodotoxin and 
cadmium or blockade of the postsynaptic ACh response with tetrodotoxin and mecamylamine was found to up-
regulate P2X purinoceptor expression in the wholemount submandibular ganglion preparation (M.A. Hansen 
and D.J. Adams, unpublished observations). Further investigation is warranted to determine the conditions 
necessary to up-regulate P2X purinoceptor activation in vivo. 
Purinoceptors have been localised on presynaptic nerves (Le and Li) and P2X receptors have been 
implicated in the presynaptic modulation of other neurotransmitters. It has been demonstrated in rat dorsal horn 
neurones that PPADS depresses the amplitude of evoked glutamatergic EPSCs indicating that endogenous ATP 
acts on presynaptic P2X receptors to enhance the amount of neurotransmitter released ( Li et al., 1998). Recent 
reports also describe P2X receptor modulation of adrenergic transmission in rat superior cervical ganglion 
explant cultures ( Boehm, 1999) and GABAergic transmission in cultured dorsal horn neurones from rat spinal 
cord (for review see Khakh and Henderson, 2000). It may be hypothesised that there is some factor down-
regulating the expression of the P2X purinoceptor in the intact nerve terminal. Thus, by regulating P2X 
purinoceptor expression or availability, sensitive control of neurotransmitter release could be effected. It has 
recently been demonstrated that hormones may affect P2X receptor expression in the bladder ( Yunaev et al., 
2000) suggesting that hormones or another intrinsic factor may down-regulate the expression of P2X receptors 
in vivo. 
In conclusion, in the intact submandibular ganglia preparation, ATP inhibits neurotransmitter release 
through the activation of presynaptic P2Y purinoceptors but has no effect on the postsynaptic neurones. 
However, in dissociated parasympathetic ganglion neurones, ATP evokes a transient inward current and 
increased neuronal excitability due to an up-regulation of P2X purinoceptors on the postganglionic neurones. 
Disruption of ganglionic transmission in vivo by either nerve damage or synaptic blockade may cause an 
increase in expression or availability of a different class of cell-surface receptors and mediate a membrane 
response. For example, ischaemic injury and release of ATP may up-regulate P2X receptor expression or 
availability and alter neuronal excitability in the heart and vasculature (for review see Armour, 1999). These 
observations may illustrate the inherent plasticity of the peripheral nervous system.  
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phosphate-6-azophenyl-2′,4′-disulphonic acid 
 
Acknowledgements 
 
This work was supported by grants from the National Health and Medical Research Council and Australian 
Research Council to D.J.A. 
  
 
Neuroscience (2001) 107 (2), 283-291.  doi: 10.1016/S0306-4522(01)00347-5 
 
 
References 
 
Armour, J.A., 1999. Myocardial ischaemia and the cardiac nervous system. Cardiovasc. Res. 41, pp. 41–54.  
Bo, X., Schoepfer, R. and Burnstock, G., 2000. Molecular cloning and characterization of a novel ATP P2X 
receptor subtype from embryonic chick skeletal muscle. J. Biol. Chem. 275, pp. 14401–14407.  
Boehm, S., 1999. ATP stimulates sympathetic neurotransmitter release via presynaptic P2X purinoceptors. J. 
Neurosci. 19, pp. 737–746.  
Dutton, J.L., Hansen, M.A., Balcar, V.J., Barden, J.A. and Bennett, M.R., 1999. Development of P2X receptor 
clusters on smooth muscle cells in relation to nerve varicosities in the rat urinary bladder. J. 
Neurocytol. 28, pp. 4–16.  
Edwards, F., Gibb, A. and Colquhoun, D., 1992. ATP receptor-mediated synaptic currents in the central nervous 
system. Nature 359, pp. 144–147.  
Evans, R., Derkach, V. and Surprenant, A., 1992. ATP mediates fast synaptic transmission in mammalian 
neurons. Nature 357, pp. 503–505.  
Fieber, L.A. and Adams, D.J., 1991. Adenosine triphosphate-evoked currents in cultured neurones dissociated 
from rat parasympathetic cardiac ganglia. J. Physiol. 434, pp. 239–256.  
Galligan, J.J. and Bertrand, P.P., 1994. ATP mediates fast synaptic potentials in enteric neurons. J. Neurosci. 14, 
pp. 7563–7571.  
Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth, F.J., 1981. Improved patch-clamp techniques for 
high-resolution current recording from cells and cell-free membrane patches. Pflüg. Arch. 391, pp. 85–
100.  
Hansen, M.A., Balcar, V.J., Barden, J.A. and Bennett, M.R., 1998. The distribution of single P2X1-receptor 
clusters on smooth muscle in relation to nerve varicosities in the rat urinary bladder. J. Neurocytol. 27, 
pp. 529–539.  
Hansen, M.A., Barden, J.A., Balcar, V.J., Keay, K.A. and Bennett, M.R., 1997. Structural motif and 
characteristics of the extracellular domain of P2X receptors. Biochem. Biophys. Res. Commun. 236, pp. 
670–675.  
Hansen, M.A., Bennett, M.R. and Barden, J.A., 1999. Distribution of purinergic P2X receptors in the rat heart. 
J. Auton. Nerv. Syst. 78, pp. 1–9.  
Hansen, M.A., Dutton, J.L., Balcar, V.J., Barden, J.A. and Bennett, M.R., 1999. P2X (purinergic) receptor 
distributions in rat blood vessels. J. Auton. Nerv. Syst. 75, pp. 147–155.  
Inokuchi, H. and McLachlan, E.M., 1995. Lack of evidence for P2X-purinoceptor involvement in fast synaptic 
responses in intact sympathetic ganglia isolated from guinea-pigs. Neuroscience 69, pp. 651–659.  
Kawa, K. and Roper, S., 1984. On the two subdivisions and intrinsic synaptic connexions in the submandibular 
ganglion of the rat. J. Physiol. 346, pp. 301–320.  
Khakh, B.S. and Henderson, G., 2000. Modulation of fast synaptic transmission by presynaptic ligand-gated 
cation channels. J. Auton. Nerv. Syst. 81, pp. 110–121.  
Le, K., Villeneuve, P., Ramjaun, A., McPherson, P., Beaudet, A. and Séguéla, P., 1998. Sensory presynaptic and 
widespread somatodendritic immunolocalization of central ionotropic P2X ATP receptors. 
Neuroscience 83, pp. 177–190.  
Li, P., Calejesan, A.A. and Zhuo, M., 1998. ATP P2x receptors and sensory synaptic transmission between 
primary afferent fibers and spinal dorsal horn neurons in rats. J. Neurophysiol. 80, pp. 3356–3360.  
Liu, D.-M. and Adams, D.J., 2001. Ionic selectivity of native ATP-activated (P2X) receptor channels in 
dissociated neurones from rat parasympathetic ganglia. J. Physiol. 534, pp. 423–435.  
Liu, D.-M., Katnik, C., Stafford, M. and Adams, D.J., 2000. P2Y purinoceptor activation mobilizes intracellular 
Ca2+ and induces a membrane current in rat intracardiac neurones. J. Physiol. 526, pp. 287–298.  
Luetje, C.W., Wada, K., Rogers, S., Abramson, S.N., Tsuji, K., Heinemann, S. and Patrick, J., 1990. 
Neurotoxins distinguish between different neuronal nicotinic receptor subunit combinations. J. 
Neurochem. 55, pp. 632–640.  
Nabekura, J., Ueno, S., Ogawa, T. and Akaike, N., 1995. Colocalization of ATP and nicotinic ACh receptors in 
the identified vagal preganglionic neurone of rat. J. Physiol. 489, pp. 519–527.  
Navone, F., Jahn, R., Di Gioia, G., Stukenbrok, H., Greengard, P. and De Camilli, P., 1986. Protein p38: an 
integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J. Cell Biol. 
103, pp. 2511–2527.  
Ralevic, V. and Burnstock, G., 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50, pp. 413–492.  
Seabrook, G.R. and Adams, D.J., 1989. Inhibition of neurally-evoked transmitter release by calcium channel 
antagonists in rat parasympathetic ganglia. Br. J. Pharmacol. 97, pp. 1125–1136.  
Silinsky, E.M. and Gerzanich, V., 1993. On the excitatory effects of ATP and its role as a neurotransmitter in 
coeliac neurons of the guinea-pig. J. Physiol. 464, pp. 197–212.  
 
Neuroscience (2001) 107 (2), 283-291.  doi: 10.1016/S0306-4522(01)00347-5 
 
 
Smith, A.B. and Adams, D.J., 1998. Presynaptic inhibition of neurotransmitter release by ATP in rat 
parasympathetic ganglia. J. Physiol. 513, pp. 31–32P. 
Smith, A.B., Motin, L., Lavidis, N.A. and Adams, D.J., 2000. Calcium channels controlling acetylcholine 
release from preganglionic nerve terminals in rat autonomic ganglia. Neuroscience 95, pp. 1121–1127. 
Sperlagh, B. and Vizi, E., 1991. Effect of presynaptic P2 receptor stimulation on transmitter release. J. 
Neurochem. 56, pp. 1466–1470.  
Sun, X.P. and Stanley, E.F., 1996. An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic 
nerve terminal. Proc. Natl. Acad. Sci. USA 93, pp. 1859–1863.  
Tenneti, L., Gibbons, S.J. and Talamo, B.R., 1998. Expression and trans-synaptic regulation of P2X4 and P2Z 
receptors for extracellular ATP in parotid acinar cells. J. Biol. Chem. 273, pp. 26799–26808.  
von Kugelgen, I., Stoffel, D., Schobert, A. and Starke, K., 1996. P2-purinoceptors on postganglionic 
sympathetic neurones. J. Auton. Pharmacol. 16, pp. 413–416.  
Worthington, R.A., Hansen, M.A., Balcar, V.J., Bennett, M.R. and Barden, J.A., 1999. Analysis of novel P2X 
subunit-specific antibodies in rat cardiac and smooth muscle. Electrophoresis 20, pp. 2081–2085.  
Yunaev, M.A., Barden, J.A. and Bennett, M.R., 2000. Changes in the distribution of different subtypes of P2X 
receptor clusters on smooth muscle cells in relation to nerve varicosities in the pregnant rat urinary 
bladder. J. Neurocytol. 29, pp. 99–108.  
Zhou, X. and Galligan, J.J., 1996. P2X purinoceptors in cultured myenteric neurons of guinea-pig small 
intestine. J. Physiol. 496, pp. 719–729.  
Zhou, X. and Galligan, J.J., 1998. Non-additive interaction between nicotinic cholinergic and P2X purine 
receptors in guinea-pig enteric neurons in culture. J. Physiol. 513, pp. 685–697.  
 
 
